The success of Shunxin Agriculture has completely established Henglong Capital's position within Henglong Group.
The stock price doubled, and the floating profit exceeded 500 million. Securities Regulatory Commission investigated and found his innocence--
The three results are superimposed together, and Board of Directors no longer has any doubts about Zhao Chen's investment decision.
On Monday, May 28, Henglong Group Board of Directors will be held again.
This time there were no lengthy discussions, no objections.
The proposal was submitted and passed unanimously - to inject 500 million yuan into Henglong Capital, and Zhao Chen would personally decide the investment direction without the need to apply for approval on a case-by-case basis.
Shen Jue said this after the vote:
"Zhao Chen, Henglong Capital's money is up to you. We believe in you."
Zhao Chen nodded and said nothing more.
Back in the office, Zhao Chen called Chen Xi over.
"You continue to keep an eye on the stock price of Shunxin Agriculture. If it exceeds 40, you will gradually reduce your position.
Next, your main focus is on Tongce Medical and Pianzaihuang, and continue with Add Position."
Chen Xi opened the notebook and waited for him to continue.
Zhao Chen leaned on the back of the chair and tapped his fingers on the armrest twice.
"Henglong Capital currently has 1 billion of its own funds in its account. It is still 2.5 times leveraged, with a total capital of 2.5 billion.
Tongce Medical and Pianzaihuang have already invested 1.25 billion, and there is still 1.25 billion available.
Call them all in and buy at 4.99%.
Add two at the same time, there is no upper limit, as long as it does not exceed 4.99%, you can buy as much as you want."
Chen Xi quickly ran through the numbers in his mind.
The total share capital of Tongce Medical is 447 million shares, 4.99%, approximately 22.3 million shares.
Henglong currently holds 16.85 million shares, with a shortfall of 5.45 million shares.
Based on the current stock price - she glanced at the market software, Tongce Medical closed at 48.3 yuan today - it would take about 263 million yuan for Add Position to reach 4.99%.
Pianzaihuang has a total share capital of 603 million shares, 4.99%, approximately 30.1 million shares.
Henglong currently holds 5.63 million shares, with a shortfall of 24.47 million shares.
Based on the current stock price - Pianzaihuang closed at 96.5 yuan today - it would take about 2.36 billion yuan for Add Position to reach 4.99%.
The two items total approximately 2.62 billion yuan.
The remaining available funds for Henglong Capital are 1.25 billion yuan, which is far from enough to buy 4.99%.
Chen Xi told Zhao Chen the calculated number.
Zhao Chen After listening, he was silent for two seconds, and then laughed.
"Then buy until all the funds are used up. The remaining positions of the two stocks will be allocated in proportion to their market value.
Pianzaihuang has a large gap, but the stock price is also high, and you can't buy many shares with the same money.
The gap of Tongce Medical is small, the stock price is relatively cheap, and the same money can buy more.
You divide 1.25 billion into two parts, Tongce Medical is divided into 300 million, and Pianzaihuang is divided into 950 million.
You can buy as much as you can, there is no need to deliberately pursue 4.99%, stop when you run out of funds."
Chen Xi wrote down this allocation plan in his notebook.
Zhao Chen asked again, "By the way, we invested the 1.25 billion before, what is the current profit and loss situation?"
Chen Xi turned to another page and read out the number.
"Tongce Medical, holding 16.85 million shares, cost 44.59 yuan, current stock price 48.3 yuan, floating profit per share 3.71 yuan, total floating profit approximately 62.5 million yuan.
Pianzaihuang holds a position of 5.63 million shares with a cost of 88.68 yuan. The current stock price is 96.5 yuan and the floating profit per share is 7.82 yuan. The total floating profit is about 44 million yuan.
The total floating profit of the two is about 106.5 million yuan.
Including the floating profit of Shunxin Agriculture, Henglong Capital has been established for less than two months, and Unrealized Paper Profit has exceeded 600 million."
Zhao Chen nodded. "With this achievement, Board of Directors won't say anything more."
Chen Xi closed the notebook and stood up. "Then I will prepare now. I will start tomorrow Add Position."
Tuesday, May 29th.
Chen Xi and Su Wantang sit in Trading Room again.
This time I was much calmer than the last time. With Shunxin Agriculture's record, the broker's application for financing quota went very smoothly.
The annual interest rate is still 5.8%, and the quota is 1.25 billion, which was approved on the same day.
Tongce Medical Opening Price 48.5 yuan on that day. Chen Xi was bought in three tranches:
The first tranche of 200,000 shares had a price limit of 48.6 yuan and an average transaction price of 48.55 yuan;
The second tranche of 250,000 shares had a price limit of 48.8 yuan and an average transaction price of 48.7 yuan;
The third tranche of 150,000 shares had a price limit of 48.9 yuan, and the average transaction price was 48.8 yuan.
600,000 shares were bought throughout the day, with an average price of 48.68 yuan and a transaction volume of 29.208 million.
Pianzaihuang Opening Price 96.8 yuan on that day. Chen Xi was bought in four tranches:
The first tranche of 100,000 shares had a price limit of 97.0 yuan and an average transaction price of 96.9 yuan;
The second tranche of 120,000 shares had a price limit of 97.2 yuan and an average transaction price of 97.1 yuan;
The third tranche was 80,000 shares, with a price limit of 97.5 yuan and an average transaction price of 97.4 yuan;
The fourth tranche of 50,000 shares was sold with a price limit of 97.6 yuan and an average transaction price of 97.55 yuan.
350,000 shares were bought throughout the day, with an average price of 97.17 yuan and a transaction volume of 34.01 million.
The total for that day was 63.22 million.
On May 30, Wednesday, the stock price of Tongce Medical made a slight correction, and Chen Xi seized the opportunity to buy more.
Tongce Medical 800,000 shares were bought throughout the day, with an average price of 48.0 yuan and a transaction volume of 38.4 million yuan.
Pianzaihuang bought 300,000 shares at an average price of 96.5 yuan and a transaction volume of 28.95 million. The total on that day was 67.35 million.
Thursday, May 31st.
Both stocks posted sharp intraday losses.
Chen Xi judged that it was short-term profit taking and decisively increased buying intensity.
Tongce Medical bought 1 million shares, the average price was 47.8 yuan, and the transaction volume was 47.8 million yuan.
Pianzaihuang bought 400,000 shares, with an average price of 95.8 yuan and a transaction volume of 38.32 million.
The total for that day was 86.12 million.
June 1, Friday.
Tongce Medical rebounded to 48.2 yuan, and Pianzaihuang rebounded to 96.2 yuan.
Chen Xi bought 600,000 shares of Tongce Medical as originally planned, with an average price of 48.2 yuan and a transaction volume of 28.92 million;
Pianzaihuang 300,000 shares, average price 96.2 yuan, transaction volume 28.86 million.
The total for that day was 57.78 million.
After five trading days of Add Position, Tongce Medical bought a total of 3 million shares, with an average price of 48.2 yuan and a transaction volume of approximately 144.6 million yuan;
Pianzaihuang bought a total of 1.35 million shares, with an average price of 96.4 yuan, and a transaction volume of approximately 130.1 million yuan.
The total Add Position is about 274.7 million.
The remaining available funds are approximately 975 million.
Chen Xi sent a message to Zhao Chen after the market closed:
"Zhao Zong, Add Position 275 million in the first week. Tongce Medical held a position of 19.85 million shares with a cost of 44.97 yuan;
Pien Tze Huang holds a position of 6.98 million shares with a cost of 89.88 yuan.
The total investment in the two stocks is about 1.426 billion, with a total floating profit of about 160 million. The remaining funds are 975 million, which will continue next week."
Zhao Chen replied, "Okay. Follow the rhythm, no rush."
Since Henglong Capital only started trading Add Position in April, the market does not know the situation yet.
Chen Xi believes that when the semi-annual report is disclosed, the market will be surprised.
She looks forward to this day coming, allowing the market to get to know Henglong Capital again.